Skip to main content
SpringerLink
Log in

The reactogenicity and immunogenicity of commercial Haemophilus influenzae type b conjugate vaccines

  • CORRESPONDENCE
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. Merck Research Laboratories, Merck & Co. Inc., PO Box 4 BL 1-7, West Point, PA 19486, USA e-mail: karen_kaplan@merck.com Tel.: +1-610-3973414; Fax: +1-610-3972992, , , , , , US

    Joseph F. Heyse & Karen M. Kaplan

Authors
  1. Joseph F. Heyse
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Karen M. Kaplan
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Received: 1 February 2000 and in revised form: 1 March 2000/Accepted: 26 March 2000

Rights and permissions

Reprints and permissions

About this article

Cite this article

Heyse, J., Kaplan, K. The reactogenicity and immunogenicity of commercial Haemophilus influenzae type b conjugate vaccines. Eur J Pediatr 159, 932 (2000). https://doi.org/10.1007/PL00008374

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/PL00008374

Keywords

Search

Navigation